Similar articles

• Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course.

  Henry WL, Clark CE, Epstein SE. Henry WL, et al. Circulation. 1973 Apr;47(4):827-32. doi: 10.1161/01.cir.47.4.827. Circulation. 1973. PMID: 4266759 Review. No abstract available.
• Echocardiography in the diagnosis of hypertrophic obstructive cardiomyopathy.

  Shah PM, Sylvester LJ. Shah PM, et al. Am J Med. 1977 Jun;62(6):830-5. doi: 10.1016/0002-9343(77)90649-0. Am J Med. 1977. PMID: 559411 No abstract available.
• Hypertrophic cardiomyopathy: subclassification by m mode echocardiography.

  Gilbert BW, Pollick C, Adelman AG, Wigle ED. Gilbert BW, et al. Am J Cardiol. 1980 Apr;45(4):861-72. doi: 10.1016/0002-9149(80)90133-2. Am J Cardiol. 1980. PMID: 6444777 Review. No abstract available.
• Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS.

  Henry WL, Clark CE, Epstein SE. Henry WL, et al. Circulation. 1973 Feb;47(2):225-33. doi: 10.1161/01.cir.47.2.225. Circulation. 1973. PMID: 4734345 No abstract available.
• Current operative treatment of obstructive hypertrophic cardiomyopathy.

  McIntosh CL, Maron BJ. McIntosh CL, et al. Circulation. 1988 Sep;78(3):487-95. doi: 10.1161/01.cir.78.3.487. Circulation. 1988. PMID: 3409494 No abstract available.